Isomorphic Labs Stock
Private company — Isomorphic Labs is privately held. Its shares are not listed on any public exchange and can only be accessed through private secondary transactions.
Status source: AXEVIL investment team
Data last updated: 6 August 2026
About Isomorphic Labs
British AI drug-discovery company spun out of Google DeepMind, built on the AlphaFold 3 model. Raised its first outside round, $600M, in March 2025 led by Thrive Capital with GV and Alphabet participating. The company's valuation has not been publicly disclosed.
Isomorphic Labs designs drugs using AI: the IsoDDE engine immediately constructs a molecule for a specific target instead of years of trial and error in the lab. The company was founded by Demis Hassabis (CEO Google DeepMind, Nobel laureate in chemistry 2024 for AlphaFold) and spun out of DeepMind into a standalone business. Partnerships with Eli Lilly, Novartis, and Johnson & Johnson are already bringing in upfront payments and milestone payments (potential ~$3 billion), revenue is growing exponentially year-over-year (~$95M in 2025). ~$2.6 billion has been raised, including Series B $2.1 billion (May 2026, the second-largest biotech round in history) with support from Alphabet. By the end of 2026, the first clinical trials of its own AI-drug are expected; target entry — August 2026, exit via IPO ~2030.
- Sector: AI / Healthcare
- Headquarters: London, United Kingdom
- Founded: 2021
Latest news
- Demis Hassabis steps down as CEO of Google DeepMind and strengthens focus on Isomorphic Labs — 6 August 2026
- Google DeepMind disbanded the Nobel-winning AlphaFold team — 29 July 2026
Frequently asked questions
Can I buy Isomorphic Labs stock?
Not on a public exchange — Isomorphic Labs is privately held. Shares change hands only in private secondary transactions. AXEVIL structures those as dedicated US special purpose vehicles for accredited investors, subject to availability and to the rules of your jurisdiction.
How much is one Isomorphic Labs share?
A private company has no single official price. AXEVIL does not publish a consensus share-price estimate for this company at the moment.
When will Isomorphic Labs IPO?
No listing has been announced. AXEVIL does not forecast IPO dates — this page states what has actually been filed or reported, with the date it was last checked.
Is Isomorphic Labs publicly traded?
No. Isomorphic Labs is a private company and its shares are not listed on any public exchange.
Similar companies
- Abridge — AI / Healthcare
Risk disclosure
Nothing on this page is an offer to sell or a solicitation to buy any security, and it is not investment advice. Valuations and share prices shown here are AXEVIL estimates built from primary sources — filings, announced rounds and completed secondary transactions — not quoted market prices, and they can be revised. Private-company shares are illiquid, may be impossible to sell, and the entire amount invested can be lost. Availability depends on your jurisdiction and on accredited-investor status.